Chroma Bio, Inc.
Financial Services · Biotechnology
Key facts
These are the key facts about Chroma Bio, Inc. on Alion as of Nov 13, 2026. Chroma Bio, Inc. is headquartered in Boston, United States. It was founded in 2003. The latest round is Venture - Series Unknown of $135M, announced in 2023.
- Headquarters
- Boston, United StatesAlion company profile, updated Nov 12, 2026
- Founded
- 2003Alion company profile, updated Nov 12, 2026
- Employees
- 500+Alion company profile, an estimated range
- Total raised
- $135MSum of 1 equity round Alion knows
- Latest round
- Venture - Series Unknown · $135M · Feb 8, 2023SEC Form D filing · sec.gov
Official records
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as nChroma Bio, Inc., Boston, MA
Other sponsors in the same field
Keros Therapeutics 9 roles
Scribe 2026 Privacy Policy Site by Bunsen
Amplify Surgical
Daiichi Sankyo 28 filings
Alert me
US Department of Labor · latest filing Apr 23, 2025 · Visa details by country
Financials
Total raised
$135M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2023 | $135M | Details |
People
Brett Kaplan
Executive Officer
Vic Myer
Executive Officer
Catherine Stehman-Breen
Executive Officer, Director
George Golumbeski
Director
Thomas Cahill
Director
Bihua Chen
Director
Michael Kelly
Director
Jeff Marrazzo
Director
Kevin Bitterman
Director
Paola Pozzi
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Atlas VentureVia a fund
ARCH Venture PartnersVia a fund
Sofinnova PartnersVia a fund
Omega FundsVia a fund
Wellington ManagementVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Media nChroma Bio Raises 75M to Advance Epigenetic Editing for Hepatitis B and D Cure December 13, 2024 ContagionLive
Read more
Report
Chroma, Nvelop startups merge to form nChroma Bio
Two Massachusetts-based biotechs, Chroma Medicine and Nvelop Therapeutics, have merged to form nChroma Bio.
Read more
Report
Chroma, Nvelop merge to marry genetic medicine 'cargo' to delivery
The combined company, which will pair Chroma's epigenetic editing with Nvelop's non-viral particles, has raised $75 million from a broad syndicate.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ
Where To Find Us
500-1000 est. staff
201 Brookline Avenue, Boston, MA 02215
How to cite this page
Alion, "Chroma Bio, Inc.: key facts", as of Nov 13, 2026. https://alion.io/company/nchromabio
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0